Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19.
Backer V, Sjöbring U, Sonne J, Weiss A, Hostrup M, Johansen HK, Becker V, Sonne DP, Balchen T, Jellingsø M, Sommer MOA. Backer V, et al. Among authors: sonne j, sonne dp. Lancet Reg Health Eur. 2021 May;4:100084. doi: 10.1016/j.lanepe.2021.100084. Epub 2021 Apr 6. Lancet Reg Health Eur. 2021. PMID: 33842908 Free PMC article.
Effects of liraglutide on gallbladder emptying: A randomized, placebo-controlled trial in adults with overweight or obesity.
Nexøe-Larsen CC, Sørensen PH, Hausner H, Agersnap M, Baekdal M, Brønden A, Gustafsson LN, Sonne DP, Vedtofte L, Vilsbøll T, Knop FK. Nexøe-Larsen CC, et al. Among authors: sonne dp. Diabetes Obes Metab. 2018 Nov;20(11):2557-2564. doi: 10.1111/dom.13420. Epub 2018 Jul 10. Diabetes Obes Metab. 2018. PMID: 29892986 Free PMC article. Clinical Trial.
Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial.
Kårhus ML, Brønden A, Forman JL, Haaber A, Knudsen E, Langholz E, Dragsted LO, Hansen SH, Krakauer M, Vilsbøll T, Sonne DP, Knop FK. Kårhus ML, et al. Among authors: sonne dp. Lancet Gastroenterol Hepatol. 2022 Oct;7(10):922-931. doi: 10.1016/S2468-1253(22)00198-4. Epub 2022 Jul 20. Lancet Gastroenterol Hepatol. 2022. PMID: 35868334 Clinical Trial.
Protocol for a randomised, double-blinded, placebo-controlled, double-dummy 6-week clinical trial comparing the treatment effects of the glucagon-like peptide 1 receptor agonist liraglutide versus the bile acid sequestrant colesevelam on bile acid malabsorption.
Kårhus ML, Brønden A, Lyng Forman J, Haaber A, Vilsbøll T, Sonne DP, Knop FKK. Kårhus ML, et al. Among authors: sonne dp. BMJ Open. 2021 Feb 8;11(2):e044711. doi: 10.1136/bmjopen-2020-044711. BMJ Open. 2021. PMID: 33558360 Free PMC article.
Bile acid-farnesoid X receptor-fibroblast growth factor 19 axis in patients with short bowel syndrome: The randomized, glepaglutide phase 2 trial.
Hvistendahl MK, Naimi RM, Hansen SH, Rehfeld JF, Kissow H, Pedersen J, Dragsted LO, Sonne DP, Knop FK, Jeppesen PB. Hvistendahl MK, et al. Among authors: sonne dp. JPEN J Parenter Enteral Nutr. 2022 May;46(4):923-935. doi: 10.1002/jpen.2224. Epub 2021 Sep 1. JPEN J Parenter Enteral Nutr. 2022. PMID: 34287979 Clinical Trial.
70 results